JPMorgan Resumes Pfizer (PFE) at Overweight

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/30/2026

1. INTC
2. AMZN
3. PINS
4. COIN
5. RDDT
6. FSLR
7. SYK
8. SBUX
9. SNDK
10. MA

Go back to JPMorgan Resumes Pfizer (PFE) at Overweight

Jefferies Reiterates Buy on Pfizer (PFE) Post Allergen Collapse, PT Trimmed to $39

April 7, 2016 8:23 AM EDT

Jefferies analyst, Jeffrey Holford, performed a SOTP valuation on fizer (NYSE: PFE) after the Allergan deal was terminated and believes shares have 18% upside by 2017 as the decision on the split has been reinstated to 2016. He also sees the potential for major M&A to give more critical mass to GIP in particular. Using a SOTP analysis, he derives a value of... More

Pfizer (PFE) Announces Termination of Merger Agreement with Allergan (AGN)

April 6, 2016 6:45 AM EDT

Pfizer Inc. (NYSE: PFE) announced that the merger agreement between Pfizer and Allergan plc (NYSE: AGN) has been terminated by mutual agreement of the companies. The decision was driven by the actions announced by the U.S. Department of Treasury on April 4, 2016, which the companies concluded qualified as an Adverse Tax Law Change... More